Clinical Trial

Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Monotherapy

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This is a prospective, multicenter, randomized, parallel controlled study to evaluate the effectiveness of Huaier Granule in preventing recurrence and metastasis after radical resection of colorectal cancer
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-10-15; most recent amendment 2025-05-06.
Status change: Not Yet Recruiting → Recruiting 2025-03-10
Trial Details
NCT Number NCT06090994
Lead Sponsor Fudan University
Collaborators: Huazhong University of Science and Technology
Conditions Colorectal Cancer
Enrollment 756 participants
Start Date 2024-10-18
Primary Completion 2027-07 (estimated)
Study Completion 2029-11 (estimated)
Updated on ClinicalTrials.gov 2025-05-07